A prospective study showed that patients with higher amounts of urinary galectin-3 (≥510.8 pg/mL) compared to those with lower galectin-3 levels (≤354.6 pg/mL) had a 4.6-fold higher risk of kidney disease progression (Figure 4). This evidence concerns the gene LGALS3 and kidney disorder.